Science Saves Lives

New technologies and scientific understanding give hope and a future to millions of people. 🧬🔬💊

[Science Saves Lives @ScSavesLives]

Scientists are pursuing a new way to treat multiple sclerosis.

BTK inhibitors are designed to temper the immune attacks that damage the nervous system. Now remibrutinib has succeeded in two Phase 3 trials for relapsing MS.

Investment in science makes breakthroughs possible.

[Science Saves Lives @ScSavesLives]

An mRNA treatment that helps keep melanoma from returning. A new flu vaccine. Early research pointing toward treatments for pancreatic cancer and simpler CAR-T therapy.

None of these breakthroughs happened overnight. They are the return on sustained investment in science.

[Science Saves Lives @ScSavesLives]

University of California is asking Congress to address steep declines and delays in federal research funding that are forcing hiring freezes and disrupting potentially lifesaving research. https://t.co/KPpLR7vTp0

[Science Saves Lives @ScSavesLives]

In 2025, California's life sciences industry generated $394 billion in economic activity and supported more than 1.08 million jobs across the state.

Scientific research is an investment in better health, good jobs and California’s future.

[Science Saves Lives @ScSavesLives]

The California Institute for Regenerative Medicine is investing in a new program to accelerate the development of therapies for the 30 million people in the United States living with rare diseases.

[Science Saves Lives @ScSavesLives]

At a time when federal research funding is uncertain, @CIRMnews announced that its $662 million budget will fund stem cell and gene therapy research, expand access to clinical trials, and train the next generation of scientists.

Public investment gives scientists the time, tools and talent to pursue answers patients are still waiting for.

[Science Saves Lives @ScSavesLives]

Exciting News in Asthma Research. Arrowhead Pharmaceuticals, Eli Lilly and Company, and GlaxoSmithKline are at the forefront of the next generation of therapies. Recent reports indicate that several innovative drugs are undergoing phase 2 clinical trials to assess their effectiveness and safety. This research could be a game-changer for millions living with asthma. #ScienceSavesLives

[Science Saves Lives @ScSavesLives]

Other countries are actively recruiting scientists trained in the U.S. because they recognize the value of science: it provides cures, vaccines, medical devices, biotech jobs, and breakthroughs shaping the future. https://t.co/QiZ90CkonH

[Science Saves Lives @ScSavesLives]

New FDA-approved treatments, like Leqembi and Kisunla, are among the first disease-modifying options shown to slow cognitive decline in some early Alzheimer’s patients.

They are not cures. But they are progress.

Every breakthrough provides researchers more knowledge, doctors more tools, and families more hope.

[Science Saves Lives @ScSavesLives]

The U.S. still leads the world in biotech innovation — but that lead is not guaranteed.

A new Reuters report finds China is rapidly gaining ground in clinical development and drug research, while the U.S. remains strongest in commercialization, capital access, manufacturing, and talent.

To keep leading, we have to keep investing in the scientists, labs, universities, companies, and clinical trials that turn discovery into lifesaving medicine.

[Science Saves Lives @ScSavesLives]

A new FDA pilot program aims to speed up early-stage clinical trials by 6 to 12 months — helping promising therapies move more quickly from the lab to patients.

That matters because every month counts when families are waiting for new options. #ScienceSavesLives

[Science Saves Lives @ScSavesLives]

Cancer can come back because a tiny number of cells survive treatment. @UCSF scientists are using robots to find them.

Researchers built a platform that tests thousands of mini-tumors at once — speeding up what would have taken 10,000 week-long experiments by hand.

This is what progress looks like: new tools, deeper understanding, and new hope for stopping cancer before it returns. #ScienceSavesLives

[Science Saves Lives @ScSavesLives]

🧬 Cancer treatment is becoming more personalized than ever.

New research presented at ASCO Annual Meeting showed encouraging results for patients with ESR1-mutated breast cancer using a combination of:

✔️ CDK4/6 inhibitors
✔️ Camizestrant
✔️ Targeted hormone therapy strategies

The result? Longer progression-free survival and new hope for patients whose cancers have become resistant to standard therapies.

Scientific innovation is transforming cancer from a one-size-fits-all disease into a highly targeted fight. 💙

[Science Saves Lives @ScSavesLives]

Exciting News in Asthma Research. Arrowhead Pharmaceuticals, Eli Lilly and Company, and GlaxoSmithKline are at the forefront of the next generation of therapies. Recent reports indicate that several innovative drugs are undergoing phase 2 clinical trials to assess their effectiveness and safety. This research could be a game-changer for millions living with asthma. #ScienceSavesLives

[Science Saves Lives @ScSavesLives]

A San Diego biotech company is working with U.S. health officials to provide an experimental treatment as Ebola cases continue to rise in Central Africa. Researchers believe the antibody therapy could help fight the strain driving the outbreak.

The next global health breakthrough may already be sitting inside a California laboratory today. #SavetheScientists

[Science Saves Lives @ScSavesLives]

For forty years, California has been a global leader in biotech treatments, cures, jobs, investment, and economic growth. #SavetheScientists

[Science Saves Lives @ScSavesLives]

Researchers and scientists in South Africa have launched clinical trials on the first domestically developed vaccine. This is a significant milestone for vaccine access in the country and across the rest of the continent. #ScienceSavesLives

[Science Saves Lives @ScSavesLives]

Asthma treatment has seen some pretty major developments over the past year, especially in biologics, precision medicine, and long-acting therapies.
#ScienceSavesLives

[Science Saves Lives @ScSavesLives]

The FDA approved the first-ever gene therapy for a rare, congenital form of deafness. The maker of the treatment, @Regeneron, will provide the therapy free of charge to patients in the United States.